We are live on !
Find out more
Manning & Napier Advisors Portfolio holdings
AUM
$7.8B
Turnover
32.88%
1-Year Est. Return
25.03%
This Fund
S&P 500
This Quarter Est. Return
+15.96%
1 Year Est. Return
+25.03%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.8B
AUM Growth
+$707M
(+10%)
Cap. Flow
-$136M
Cap. Flow % of AUM
Cap. Flow %
-1.74%
Top 10 Holdings %
Top 10 Hldgs %
31.71%
Holding
885
New
270
Increased
236
Reduced
238
Closed
21
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tenet Healthcare
THC
|
+$166M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$157M |
| 3 |
Knight Transportation
KNX
|
+$154M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$133M |
| 5 |
Ametek
AME
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$96.8M |
| 2 |
TransUnion
TRU
|
+$88M |
| 3 |
Cadence Design Systems
CDNS
|
+$71.2M |
| 4 |
Sabesp
SBS
|
+$70.6M |
| 5 |
NVIDIA
NVDA
|
+$65.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Miscellaneous | 18.14% |
| 3 | Financials | 13.71% |
| 4 | Healthcare | 12.57% |
| 5 | Consumer Discretionary | 9.57% |
Similar funds
Manning & Napier Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Manning & Napier Advisors held 885 positions worth $7.8B, up 10% from $7.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Manning & Napier Advisors's Q2 2026 filing shows 270 new, 236 increased, 238 reduced and 21 closed positions. Its largest new stake was Tenet Healthcare: 901,645 shares worth $169M. The largest sale was Vertex Pharmaceuticals, an estimated $96.8M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Miscellaneous and Financials.
- Manning & Napier Advisors's largest Q2 2026 buy was Tenet Healthcare: 901,645 shares worth $169M.
- Manning & Napier Advisors added most to Vanguard Intermediate-Term Treasury ETF in Q2 2026, an estimated $157M increase.
- Manning & Napier Advisors's biggest Q2 2026 reduction was Vertex Pharmaceuticals, cutting an estimated $96.8M.
- Manning & Napier Advisors fully exited Plains All American Pipeline in Q2 2026, selling an estimated $4.47M.
- Manning & Napier Advisors's ten largest holdings make up 32% of its $7.8B portfolio in Q2 2026.
- Manning & Napier Advisors opened 270 new positions and closed 21 in Q2 2026.
- Manning & Napier Advisors's portfolio value rose 10% quarter-over-quarter to $7.8B.
Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.